
KFSHRC Command Center atthe core of digital transformation and care excellence
King Faisal Specialist Hospital & Research Centre (KFSHRC) has advanced healthcare efficiency through its Capacity Command Center, a strategic pillar in the hospital's digital transformation journey. The Center has significantly optimized hospital-wide performance while delivering more responsive, patient-centered care.
Established to modernize operations and elevate care, the Center provides real-time visibility across the patient journey—from admission to discharge—powered by a locally developed color-coded alert system that flags bottlenecks and enables timely intervention. This has improved operational efficiency and patient experience by streamlining admissions, discharges, and transfers, resulting in faster recovery, better resource use, and smoother clinical handovers.
Building on this foundation, the Center leverages AI and big data to forecast patient volumes, identify pressure points, and guide precise resource allocation. These capabilities are reinforced by ongoing technical reporting, data mining, and performance reviews that translate insights into continuous institutional improvement.
These innovations have led to a 14% reduction in average length of stay (ALOS) and a 19% drop in emergency department congestion, boosting patient recovery, bed availability, and patient safety. In parallel, overall hospital activity grew, with new patient admissions increasing by 10.3% to 46,476 in 2024, reflecting enhanced throughput and capacity management.
Central to KFSHRC's transformation agenda, the Command Center exemplifies how AI and real-time analytics enable predictive, evidence-based decisions, advancing its mission to deliver high-quality, specialized care through a scalable intelligent healthcare model.
It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
13 hours ago
- Zawya
Middle East pharma market on track for $36bln by 2028
JLL's EMEA Life Sciences Industry Perspective and Cluster Report reveals AI and venture capital are fuelling a surge in demand for next-generation labs The Middle East's pharmaceutical market is projected to reach US$36 billion by 2028, with a CAGR of 7.7% from 2023 GCC governments are prioritizing digital transformation and investing in local generic drug manufacturing and biosimilar development to boost sector growth Dubai, United Arab Emirates: Fuelled by significant government investments in R&D and manufacturing infrastructure, and a strategic push towards greater local innovation and production, the Middle East's life sciences industry is poised for substantial growth, according to JLL's latest EMEA Life Sciences Industry Perspective and Cluster Report. The region's pharmaceutical market is projected to reach US$36 billion by 2028, and this robust expansion, set for a Compound Annual Growth Rate (CAGR) of 7.7% from 2023, is further amplified by digital transformation initiatives and comprehensive industrialisation strategies across the Gulf Cooperation Council (GCC). As the life sciences market develops globally, countries in the GCC are accelerating their capabilities in the sector to boost innovation, reduce import reliance, and diversify their economies. The JLL report, which explores the key drivers shaping EMEA's life sciences industry and its impact on real estate markets, has included a high-level overview of the Middle East for the first time. The report reveals that the GCC's pivot towards becoming a global hub for life sciences innovation, research, and production is boosting demand for specialised real estate, including adequate office spaces for R&D and digital health, and manufacturing locations that require warehouse and distribution assets. Mireille Azzam, Head of Strategic Consulting, JLL Middle East and Africa (MEA) said:'Innovation is critical for success in the life sciences industry, and the GCC is building self-reliance by incubating innovative ventures and creating a collaborative environment to scale research and expand its pool of skilled workforce. From flexible lab designs and resilient building systems, the increased focus on creating spaces primed for scientific breakthroughs and growth is directly translating into a dynamic real estate market. The growing demand for purpose-built facilities will support groundbreaking research, advanced manufacturing, and drive digital transformation, laying a strong foundation for the future growth of the region's evolving life sciences ecosystem.' Amidst increasing global competition and tariff uncertainty, JLL's latest report highlights several overarching trends shaping the life sciences real estate landscape across EMEA. Artificial Intelligence (AI) and venture capital are driving demand for next-generation labs, and the report highlights AI's dual impact in accelerating scientific discovery and revolutionising real estate management through increased efficiency from research to distribution. New supply delivered by investors is progressively addressing historical lab space shortages, shifting away from public or owner-occupier driven models, with top-tier assets in prime locations expected to prevail. The JLL report highlights that the sector's commitment to sustainability is driving demand for greener lab buildings. These dynamics underscore how life sciences clusters, from Europe to the Middle East and Africa, possess distinctive strengths, with locations like the Golden Triangle, Johannesburg, and Riyadh leading in biopharma research, while others excel in digital health or manufacturing. The GCC's increasing commitment to life sciences JLL's analysis of the major life sciences city-clusters in the GCC reveals significant transformations across the three prominent subsectors of Biopharma R&D, Digital Health and Tech R&D, and Pharmaceutical Manufacturing. Driven by the increasing prevalence of chronic diseases and a focus on personalised medicine and genomics research, JLL notes a profound shift in the Biopharma and drug discovery sector. As targeted therapies gain prominence, government investments in local generic drug manufacturing and biosimilar development are accelerating, with innovative research in cell and gene therapy also primed for significant growth. Dubai Science Park in the UAE and Qatar Science and Technology Park have emerged as regional hubs for biopharma R&D, while Saudi Arabia's position in the regional drug discovery landscape is strengthened through strategic partnerships and ongoing investments in pharmaceutical research and manufacturing. To improve accessibility, efficiency, and patient outcomes in the healthcare sector, GCC governments have prioritised digital transformation, driving growth in telehealth, remote patient monitoring, and AI-powered diagnostics. The emergence of health-tech startups and a growing emphasis on preventive healthcare are also contributing to sector growth. Regional hubs such as the UAE's Dubai Healthcare City and Healthpoint in Abu Dhabi, and Saudi Arabia's NEOM project are driving the surge in digital health adoption and investment, and fostering innovation and attracting talent. Through investments in industrial parks and by providing incentives for manufacturers, GCC governments are diversifying the region's Pharmaceutical Manufacturing sector. Alongside the adoption of advanced manufacturing technologies to boost efficiencies, growth in this sector is driven by affordable energy, strategic geographic locations, and increasing local content requirements. The UAE's Jebel Ali Free Zone and Dubai Industrial City, alongside Saudi Arabia's King Abdullah Economic City and Sudair Industrial City, stand out as key manufacturing hubs. These locations offer advanced infrastructure and logistical advantages, successfully attracting both domestic and international pharmaceutical companies. The region's commitment to life sciences is further bolstered by its strong academic credentials, as institutions such as King Saud University in KSA, Qatar University, and the United Arab Emirates University earn top spots in global life sciences university rankings. About JLL For over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500® company with annual revenue of $23.4 billion and operations in over 80 countries around the world, our more than 112,000 employees bring the power of a global platform combined with local expertise. SEE A BRIGHTER WAYSM. About JLL MEA Across the Middle East and Africa (MEA) JLL is a leading player in the real estate and hospitality services markets. The firm has worked in 35 countries across the region and employs over 2000 internationally qualified professionals across its offices in Dubai, Abu Dhabi, Riyadh, Jeddah, Al Khobar, Cairo, Casablanca, Cape Town, Johannesburg and Nairobi.


Zawya
13 hours ago
- Zawya
South Africa: Medshield is committed to building a sustainable healthcare future
Are you curious about what makes businesses stand out in our current environment? It's certainly not about the bottom line and the financials anymore. It's about how they impact the world – the environment, the societies in which they operate, and their governance structures. Environmental, Social, and Governance (ESG) principles have become indispensable in a world grappling with climate change, social inequalities, and corporate accountability. While sectors like mining, energy, and manufacturing have typically been under the ESG spotlight, healthcare is now stepping into focus. Integrating ESG principles is crucial for medical schemes to ensure the future sustainability of healthcare. Factors such as escalating costs, the rise of lifestyle-related diseases, and the environmental impact of medical waste make ESG adoption necessary. Medshield Medical Scheme aligns sustainability with healthcare excellence by developing an ESG roadmap featuring clear corporate sustainability goals. This effort sets the benchmark for responsible healthcare funding in South Africa, paving the way for a more resilient healthcare system. Learning from South African ESG leaders Medshield acknowledges the importance of gaining insights from industry leaders who have effectively integrated ESG principles into their business models. Locally, Life Healthcare is actively driving sustainable healthcare by incorporating energy efficiency and water-saving measures across its hospital network. Aspen Pharmacare, one of South Africa's largest pharmaceutical companies, has embedded ESG principles into its global operations – most notably with sustainable manufacturing practices and community health support initiatives. Sanlam has demonstrated leadership in sustainable investment practices, governance transparency, and transformation targets in the insurance sector, aligning financial strength with social progress. Novartis South Africa also contributes to local ESG progress through public-private partnerships to expand access to healthcare and drive inclusive health equity. By benchmarking against these homegrown leaders and learning from their practical examples, Medshield aims to refine and strengthen its ESG roadmap. Although still in its preliminary stages, Medshield is laying the foundation for meaningful impact. 1. Environmental impact: Pollution and waste management Environmental sustainability is a fundamental ESG pillar, and healthcare providers must tackle pollution and waste management. The healthcare sector produces substantial medical, pharmaceutical, and electronic waste, which can result in severe environmental consequences if not meticulously managed. Life Healthcare has taken a proactive role in managing medical waste and improving energy usage within hospital environments. Aspen Pharmacare has also been recognised for its commitment to reducing environmental impact through improved production technologies and waste reduction systems. Inspired by these local initiatives, Medshield is exploring energy-efficient infrastructure and renewable energy solutions to reduce its environmental footprint and contribute to sustainable healthcare. 2. Social impact: Climate change and human health Climate change poses an escalating threat to public health. Rising temperatures and pollution levels contribute to lifestyle ailments such as hypertension, diabetes, and respiratory conditions. Medshield recognises its responsibility to mitigate these health risks through preventive healthcare programmes, chronic disease management, and promoting wellness benefits to its members. In parallel, Novartis South Africa continues to lead in raising awareness and improving access to treatment for chronic diseases, with a focus on underserved communities. Medshield similarly integrates ESG principles across its internal operations to ensure alignment with corporate sustainability goals and regulatory compliance while supporting climate resilience through health. 3. Corporate responsibility: Social initiatives and member engagement ESG leaders in South Africa prioritise healthcare access and equity. Medshield is committed to extending its corporate responsibility beyond its members. The Scheme supports community health initiatives, wellness programmes, and financial literacy education. Additionally, Medshield embeds ESG principles into its corporate culture – ensuring staff engagement and promoting awareness about lifestyle changes that contribute to improved health outcomes. Aspen Pharmacare, for instance, has significantly contributed to healthcare equity through community-based partnerships and access to essential medicines. Sanlam has also implemented financial literacy initiatives nationwide to drive socioeconomic upliftment. Medshield is actively learning from and contributing to this ecosystem of shared value creation. 4. Governance: The pillar of corporate sustainability Strong governance ensures transparency, accountability, and long-term sustainability. Medshield prides itself on having a robust governance structure and is adopting best practices to strengthen its corporate governance. The Scheme is exploring partnerships with ESG-focused healthcare networks for ongoing improvement and intends to integrate ESG reporting into its annual trustee and Annual General Meeting (AGM) reports to strengthen transparency and accountability. Sanlam's comprehensive sustainability disclosures and Life Healthcare's transparent ESG frameworks offer useful templates for Medshield's ongoing governance enhancement. By drawing from these examples, Medshield aims to ensure that ESG isn't a side initiative but a core part of the Scheme's operation. Medshield is a responsible corporate citizen Medshield's ESG journey signifies its dedication to being a responsible corporate citizen. By embedding ESG principles into its business model, Medshield enhances its reputation and safeguards its operations against emerging global challenges. As one of the pioneers among South African medical schemes in undertaking a structured ESG journey, Medshield is setting a noteworthy precedent. Its approach emphasises long-term resilience, sustainability, and member-centric healthcare solutions. As Medshield refines its ESG initiatives, the greater healthcare sector benefits from a model prioritising people, the planet, and strong governance. ESG is not merely a trend – it is the future of responsible healthcare, and Medshield is at the forefront of this transformation in South Africa. We invite all members, brokers, and stakeholders to join us in shaping a more sustainable and inclusive healthcare future.

Zawya
14 hours ago
- Zawya
Dr. Rasha Kelej drives an impactful change in public health landscape in Africa and beyond by providing 2282 scholarships to doctors from 52 countries
Merck Foundation ( the philanthropic arm of Merck KGaA Germany marks 'World Health Day' 2025 in partnership with Africa's First Ladies who are also the Ambassadors of Merck Foundation 'More Than a Mother' Campaign, with a strong reaffirmation of its commitment to improving and revolutionizing healthcare access across Africa, Asia and beyond through their Scholarships and Capacity Building Program. Senator, Dr. Rasha Kelej, CEO of Merck Foundation shared, 'For over last 13 years, our efforts at Merck Foundation have been to ensure equitable access to healthcare through education, training and awareness initiatives that not only helps transform the patientcare landscape in Africa and Asia but also empower communities and medical professionals. I am proud to share that together with our Ambassadors, the First Ladies of Africa, we mark World Health Day every single day of the year by building healthcare capacity and transforming patient care landscape. We achieve this by providing more than 2282 scholarships to young doctors providers across 52 countries in Africa, Asia, and beyond, in 44 critical and underserved medical specialties such as Oncology, Diabetes, Preventative Cardiovascular Medicine, Endocrinology, Sexual and Reproductive Medicine, Acute Medicine, Respiratory Medicine, Embryology&Fertility specialty, Gastroenterology, Dermatology, Psychiatry, Emergency and Resuscitation Medicine, Critical Care, Pediatric Emergency Medicine, Neonatal Medicine, Advanced Surgical Practice, Pain Management, General Surgery, Clinical Microbiology and infectious diseases, Internal Medicine, Trauma&Orthopedics, Neurosurgery, Neurology, Cardiology, Stroke Medicine, Care of the Older Person, Family Medicine, Pediatrics and Child Health, Obesity&Weight Management, Women's Health and many more.' As per a WHO, African region has a ratio of only 1.55 health workers including physicians, nurses and midwives per 1000 people*. This is below the WHO threshold density of 4.45 health workers per 1000 people needed to deliver essential health services and achieve universal health coverage. Therefore, the Merck Foundation scholarships are highly significant, as they provide doctors with specialized training, helping to bridge healthcare gaps and improve patient care in underserved communities. Senator Dr. Rasha Kelej emphasized, 'Before the launch of Merck Foundation programs in 2012, many countries—including The Gambia, Liberia, Sierra Leone, the Central African Republic, Guinea, Burundi, Niger, Chad, Ethiopia, Namibia, Myanmar, and Bangladesh—had either no or very few specialists in critical fields such as Oncology, Fertility and Reproductive Care, Diabetology, Respiratory Medicine, and Intensive Care. I am proud to share that many of our alumni have become, or are on their way to becoming, the first specialists in their respective countries. We are building a lasting legacy in Africa.' Merck Foundation works closely with their Ambassadors, the African First Ladies and local partners such as Ministries of Health, Education, Information&Communication, Gender, Academia, Research Institutions, Media and Art in building healthcare capacity and addressing health, social&economic challenges in developing countries and under-served communities. Dr. Kelej shared, 'This year's theme, 'Healthy Beginnings, Hopeful Futures,' aligns perfectly with our initiatives to educate young minds on the importance of a healthy lifestyle, as well as diabetes and hypertension awareness. Together with First Ladies of Africa, we have launched two storybooks on these health topics and adapted them into engaging and inspiring animated films'. Watch Sugar Free Jude Animation Film: Watch Mark's Pressure Animation Film: Merck Foundation also launches awards for the best media, film, fashion designs, and songs on these themes to encourage local artists and young talents to raise awareness about the importance of a healthy lifestyle in their communities, through their everyday work. Merck Foundation believes that training healthcare providers and building professional healthcare capacity is key to ensuring equitable and quality healthcare across Africa. 'I am happy to announce the Call for Applications for our 2025 Scholarships for young doctors with special focus on female doctors. These include one-year diploma and two-year master degree in 44 critical and underserved medical specialties, which includes both On-Site Fellowship and clinical training programs and Online Diploma programs. The applications are invited through the Office of our Ambassadors and long-term partners, The First Ladies of Africa and Ministry of Health of each country,' shared Senator Dr Rasha Kelej. To Apply for In campus Scholarships: To Apply for Online Scholarships, visit: The selection for each scholarship will be based on request by First Lady Office, Ministry of Health and / or Medical Society with the aim to fill the gaps of public healthcare system in each country. The selection will be based on eligibility criteria fulfillment of each training Institute and Foundation, scholarship availability and fund availability. Distributed by APO Group on behalf of Merck Foundation. Contact: Mehak Handa Community Awareness Program Manager +91 9310087613/ +91 9319606669 Join the conversation on our social media platforms below and let your voice be heard: Facebook: X: YouTube: Instagram: Threads: Flickr: Website: Download Merck Foundation App: About Merck Foundation: The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality&equitable healthcare solutions in underserved communities, building healthcare&scientific research capacity, empowering girls in education and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit to read more. Follow the social media of Merck Foundation: Facebook ( X ( Instagram ( YouTube ( Threads ( and Flickr ( The Merck Foundation is dedicated to improving social and health outcomes for communities in need. While it collaborates with various partners, including governments to achieve its humanitarian goals, the foundation remains strictly neutral in political matters. It does not engage in or support any political activities, elections, or regimes, focusing solely on its mission to elevate humanity and enhance well-being while maintaining a strict non-political stance in all of its endeavors.